A Study of a New Combination and Schedule of Chemotherapy Drugs for the Treatment of Head and Neck Cancer
Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effectiveness and side effects of a new
combination and schedule of chemotherapy drugs in the treatment of head and neck cancer.
Patients with advanced or recurrent head and neck cancer, which is untreatable by surgery or
radiation therapy are eligible for this study. Standard treatment for advanced or recurrent
head and neck cancer involves the use of chemotherapy.
Phase:
Phase 2
Details
Lead Sponsor:
University of Michigan Cancer Center University of Michigan Rogel Cancer Center